153 related articles for article (PubMed ID: 38537540)
21. The potential pathogenic roles of S100A8/A9 and S100A12 in patients with MPO-ANCA-positive vasculitis.
Bai X; Xu PC; Chen T; Zhang HM; Wu SJ; Yang X; Gao S; Jia JY; Jiang JQ; Yan TK
BMC Immunol; 2022 Sep; 23(1):42. PubMed ID: 36088289
[TBL] [Abstract][Full Text] [Related]
22. The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.
Zhang Y; Shi W; Tang S; Li J; Yin S; Gao X; Wang L; Zou L; Zhao J; Huang Y; Shan L; Gounni AS; Wu Y; Yuan F; Zhang J
Arthritis Res Ther; 2013 Oct; 15(5):R161. PubMed ID: 24286516
[TBL] [Abstract][Full Text] [Related]
23. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease.
Kambas K; Chrysanthopoulou A; Vassilopoulos D; Apostolidou E; Skendros P; Girod A; Arelaki S; Froudarakis M; Nakopoulou L; Giatromanolaki A; Sidiropoulos P; Koffa M; Boumpas DT; Ritis K; Mitroulis I
Ann Rheum Dis; 2014 Oct; 73(10):1854-63. PubMed ID: 23873874
[TBL] [Abstract][Full Text] [Related]
24. Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis.
Nishide M; Nojima S; Ito D; Takamatsu H; Koyama S; Kang S; Kimura T; Morimoto K; Hosokawa T; Hayama Y; Kinehara Y; Kato Y; Nakatani T; Nakanishi Y; Tsuda T; Park JH; Hirano T; Shima Y; Narazaki M; Morii E; Kumanogoh A
Ann Rheum Dis; 2017 Aug; 76(8):1440-1448. PubMed ID: 28416516
[TBL] [Abstract][Full Text] [Related]
25. Pharmaceutical immunoglobulins reduce neutrophil extracellular trap formation and ameliorate the development of MPO-ANCA-associated vasculitis.
Uozumi R; Iguchi R; Masuda S; Nishibata Y; Nakazawa D; Tomaru U; Ishizu A
Mod Rheumatol; 2020 May; 30(3):544-550. PubMed ID: 30932727
[No Abstract] [Full Text] [Related]
26. The involvement of NETs in ANCA-associated vasculitis.
Shiratori-Aso S; Nakazawa D
Front Immunol; 2023; 14():1261151. PubMed ID: 37781373
[TBL] [Abstract][Full Text] [Related]
27. Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA.
Kraaij T; Kamerling SWA; van Dam LS; Bakker JA; Bajema IM; Page T; Brunini F; Pusey CD; Toes REM; Scherer HU; Rabelink TJ; van Kooten C; Teng YKO
Kidney Int; 2018 Jul; 94(1):139-149. PubMed ID: 29606398
[TBL] [Abstract][Full Text] [Related]
28. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis.
Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165
[TBL] [Abstract][Full Text] [Related]
29. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.
Schreiber A; Rousselle A; Becker JU; von Mässenhausen A; Linkermann A; Kettritz R
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9618-E9625. PubMed ID: 29078325
[TBL] [Abstract][Full Text] [Related]
30. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
[TBL] [Abstract][Full Text] [Related]
31. [The expression and clinical significance of neutrophil myeloperoxidase in patients with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Liu Y; Peng XC; Xu JN; Zheng MJ; Shuai ZW
Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1016-1022. PubMed ID: 36008294
[No Abstract] [Full Text] [Related]
32. High-mobility group box 1 potentiates antineutrophil cytoplasmic antibody-inducing neutrophil extracellular traps formation.
Ma YH; Ma TT; Wang C; Wang H; Chang DY; Chen M; Zhao MH
Arthritis Res Ther; 2016 Jan; 18():2. PubMed ID: 26739852
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis of antimicrobial peptides LL-37 and CpG-ODN in ANCA associated vasculitis.
Luan JJ; Xing GQ
J Nephrol; 2017 Feb; 30(1):63-71. PubMed ID: 27476166
[TBL] [Abstract][Full Text] [Related]
34. Regulation of NETosis and Inflammation by Cyclophilin D in Myeloperoxidase-Positive Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Kudo T; Nakazawa D; Watanabe-Kusunoki K; Kanda M; Shiratori-Aso S; Abe N; Nishio S; Koga JI; Iwasaki S; Tsuji T; Fukasawa Y; Yamasaki M; Watanabe M; Masuda S; Tomaru U; Murakami M; Aratani Y; Ishizu A; Atsumi T
Arthritis Rheumatol; 2023 Jan; 75(1):71-83. PubMed ID: 35905194
[TBL] [Abstract][Full Text] [Related]
35. C-reactive protein enhances activation of coagulation system and inflammatory response through dissociating into monomeric form in antineutrophil cytoplasmic antibody-associated vasculitis.
Xu PC; Lin S; Yang XW; Gu DM; Yan TK; Wei L; Wang BL
BMC Immunol; 2015 Mar; 16():10. PubMed ID: 25879749
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
37. Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection.
Watanabe-Kusunoki K; Nakazawa D; Kusunoki Y; Kudo T; Hattanda F; Nishio S; Masuda S; Tomaru U; Kondo T; Atsumi T; Ishizu A
J Autoimmun; 2020 Mar; 108():102390. PubMed ID: 31883830
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of neutrophil-mediated production of reactive oxygen species (ROS) by endothelial cells is not impaired in anti-neutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitis patients.
Al Laham F; Kälsch AI; Heinrich L; Birck R; Kallenberg CG; Heeringa P; Yard B
Clin Exp Immunol; 2010 Aug; 161(2):268-75. PubMed ID: 20456419
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of an enhanced preclinical model of experimental MPO-ANCA autoimmune vasculitis.
Prendecki M; Gulati K; Turner-Stokes T; Bhangal G; Chiappo D; Woollard K; Cook HT; Tam FW; Roufosse C; Pusey CD; McAdoo SP
J Pathol; 2021 Oct; 255(2):107-119. PubMed ID: 34124781
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of citrullinated histone H3-positive neutrophils is useful for identifying active glomerular and interstitial lesions in antineutrophil cytoplasmic antibody-associated vasculitis.
Kimura H; Mii A; Shoji J; Arakawa Y; Shimizu A
Histopathology; 2021 Mar; 78(4):520-531. PubMed ID: 32956514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
